Price Alert

Virax Biolabs Group Limit... (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.77

0.03 (4.41%)

At close: Aug 15, 2025, 3:54 PM

0.77

-0.62%

After-hours: Aug 15, 2025, 07:38 PM EDT

Virax Biolabs Cash Flow Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-6.07M	-6.74M	-5.46M	-1.71M	-650.98K
Depreciation & Amortization	343.39K	103.1K	n/a	n/a	n/a
Stock-Based Compensation	365.31K	1.01M	1.73M	290.36K	n/a
Other Working Capital	-26.6K	-269.56K	-237.23K	2.19K	0.00
Other Non-Cash Items	169.34K	497.06K	-260.6K	-32.07K	1.19K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	625.62K	-1.12M	-216.28K	644.39K	59.61K
Operating Cash Flow	-4.56M	-6.25M	-4.18M	-809.07K	-590.19K
Capital Expenditures	-603.89K	-1.16M	-178.4K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-211.95K	-178.4K	n/a	n/a
Investing Cash Flow	-603.89K	-1.16M	-178.4K	n/a	n/a
Debt Repayment	-107.76K	-206.27K	146.25K	100K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	786.74K	1.85M	-111.64K	193.59K	585.2K
Financial Cash Flow	5.81M	1.65M	13.69M	813.21K	585.2K
Net Cash Flow	639.7K	-5.76M	9.33M	4.13K	-4.99K
Free Cash Flow	-5.17M	-7.41M	-4.36M	-809.07K	-590.19K